Skip to main content

Table 3 Assessment of toxicity (case, %)

From: First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer

Toxicity Grade(WHO)
  0 I II III IV
Rash 21(46.7) 19(42.2) 4(8.9) 1(2.2) 0(0)
Pruritus 35(77.8) 10(22.2) 0 0 0
Dry skin 33(73.3) 11(24.4) 1(2.2) 0 0
Diarrhea 30(66.7) 13(28.9) 2(4.4) 0 0
Oral ulcer 43(95.6) 2(4.4) 0 0 0
Nausea/vomit 37(82.2) 8(17.8) 0 0 0
Hepatic toxicity 42(93.3) 1(2.2) 2(4.4) 0 0
Interstitial lung Disease(ILD) 45(100.0) 0 0 0 0